Human immunodeficiency virus (HIV) infection and its
cosolvents and hydrotropes. clinical syndrome acquired immunodeficiency syndrome (AIDS) continue to be a major health problem Hydrotropy is a term originally coined by Neuberg 5 to worldwide. The development of highly effective describe the increase in the solubility of a solute by the antiretroviral chemotherapy for AIDS is found very addition of fairly high concentration of alkali metal salts of useful in curbing the pandemic of this disease.
various organic acids. Saleh et al. 6 Saquinavir (SQ, first protease inhibitor) is a transition extend the definition of "hydrotropic agents" to include state analogue peptide based inhibitor of the HIV cationic and non-ionic organic compounds bearing the protease protease inhibitors is their high cost; and for SQ, its low has been reported by our team. and variable oral bioavailability, which is approximately made an attempt to , and nimesulide 12 4% in the fed and 1% in the fasted state 3 . Since the effect of SQ on viral replication is dose dependent and the therapy with SQ is expensive, there is an urgent need for methods to increase its bioavailability. In this present work, efforts were made to develop an economical and effective parenteral formulation of SQ with increased bioavailability and one that eliminated side effects related with oral administration of SQ. The main constraint in the development of aqueous formulation was poor solubility of drug (30 mg/l) 4 . Solubility enhancement was carried out using various *For correspondence E-mail: jnarendr@yahoo.co.in
The solubility of weak electrolyte and non-polar molecules can be increased by the addition of water miscible solvent in which drug has good solubility. This process is known as "cosolvency," and solvents used in the combination to increase the solubility of solute are known as "cosolvents" 13 . It is proposed that the cosolvent systems work by reducing the interfacial tension between predominately aqueous solution and hydrophobic solute 14 . In the present work, aqueous injection of SQ was formulated, and haemolysis study and dilution study of these formulations were carried out. Similar efforts have been reported for carbamazipine 8 www.ijpsonline.com Hydrotrope concentrations used for present investigation were 0.1-1.2 M. Germany). The resistance of different hydrotrope solutions was determined using a conductivity bridge.
MATERIALS AND METHODS

Determination of equilibrium solubility:
Observations were recorded after the solutions had Excess of SQ was added to screw-capped 10 ml amberequilibrated in a water bath at 25±2° ( (Table 2) , aqueous and hydrotrope were recorded on a double-beam injections of SQ using cosolvents and hydrotropes were spectrophotometer (GBC, Cintra 10). The pH of formulated. In each case, except formulation containing different hydrotropes alone and in the presence of ascorbic acid, 0.1% (w/v) sodium bisulfite was added to drug was measured at 25±2° using a digital pH meter (Elico Pvt. Ltd., Mumbai, India). The specific gravity of different hydrotrope solutions was determined at 25±2° using a 10 ml glass pyknometer [ASGI (I) Industry, Agra, India], considering water as a reference liquid. The viscosity of different solutions was determined relative to water at an ambient temperature of 25±2° using an Ostwald viscometer [ASGI (I) Industry, Agra, India]. The surface tension of different hydrotrope solutions was determined at 25±2° using stalagmometer [ASGI (I) Industry, Agra, India]. The refractive index of different hydrotrope solutions was determined at 25±2° using an Abbe refractometer (Carl Zeiss, preclude the chances of oxidation. Methyl and propyl paraben (0.018% and 0.02%) were added as preservative in each formulation. 1:5 to 1:100 and examined visually for the appearance of microcrystals. 
RESULTS AND DISCUSSION
Stability testing:
The sealed vials of the selected formulations were visually inspected daily for 45 d under fluorescent light against black and white background to detect any changes in physical appearance of the solutions, e.g., colour, turbidity, precipitation, etc. These studies were performed under room temperature in dark (RTD), freezing temperature in dark (FTD) and temperature cycling with shaking (TCS).
On the basis of the results of simultaneous physical stability testing, the promising formulations were further subjected to exhaustive chemical stability tests at 45±2°, 55±2° and 65±2° for a period of 4 w.
Haemolysis study:
Haemolysis study (Table 3) on various formulations was performed by colorimetric methods 16 . Different formulations of SQ were incubated with 0.5 ml suspension of RBC at 25±2° for 45 min after making volume up to 10 ml with normal saline.
Dilution study:
In the present study, all four formulations of SQ were studied for effect of dilution with infusion fluids such as dimethyl urea at 25±2°. The solubility also increased by increasing temperature from 25±2° to 37±2°. This shows that solubilization of SQ is endothermic. Solubilizing power of hydrotropes could be ranked as ascorbic acid>nicotinamide>resorcinol>dimethyl urea. In a similar fashion, solubilizing power of different cosolvents could be ranked as DMF>DMA>PEG200 ( fig. 2 ).
Equilibrium solubility diagram of nicotinamide depicts slight rise in the solubility, but after 0.4 M concentration there is PEG + ethanol, and DMA cosolvents respectively normal saline and 5% dextrose solution (Table 4) These molecules may interact due to difference in electronegativity at these centres of drug and hydrotrope molecules. These interactions may be due to charge transfer phenomenon. Such weak interactions lead to planer stacking of ring system present in SQ, which causes bending of hydrophobic ring to the inside such that more hydrophilic groups are exposed to water molecules, which may account for initial linear increase in help of IR, TLC and UV spectral studies.
Negative deviation in specific gravity value was due to increase in partial molal volume upon aggregation 20 suggesting aggregate formation. Viscosity plots of hydrotropes showed positive deviation. This again indicates the increase in viscosity is due to aggregate formation 21 . Similarly, negative deviation of refractive index clearly indicates the possibility of some molecular aggregation. Apparent discontinuity (specific conductance) and decrease in conductance (equivalent conductance) are indicative of molecular aggregation 22 . Hydrotrope solutions showed decrease in surface tension in all cases but least with nicotinamide. The lowering of surface tension is due to self-association and thus supports the possibility of self-association at higher concentration in ascorbic acid vis-à-vis ruling out the possibility of same in case of nicotinamide. It was reported in literature that derivatives of ascorbic acid undergo self-association and , (a) pyridine N 2 the solubility. form micelles, thus dissolving many hydrophobic drugs 23, 24 .
The increase in solubility of SQ in ascorbic acid can be partially attributed to pH effect as SQ solubility determined in various phosphate buffers saline ranging from pH 2-9 varied to a considerable extent, and higher solubility was observed in acidic pH. This may be due to basic nature of SQ.
UV study of ascorbic acid and drug showed no shift in λ max , which rules out the chance of permanent interaction. There was no basis for assuming that there was any complex formed between the drug and In order to understand the sharp increase in the solubility of SQ above certain concentration, which is defined as critical solute concentration (CSC), various solution properties like specific gravity, relative viscosity, surface tension, specific conductance, equivalent conductance of hydrotrope solution were studied (Table 1) . At higher concentration positive deviation from linearity is characteristic of hydrotrope solubilization. This positive deviation in plots suggests that more than one molecule of hydrotrope can react with individual drug molecule 19 . Whether this aggregate formation is complexation or simple self-association can be determined from change in above-mentioned solution properties and also with the hydrotrope molecules, because the complex formation is evident by formation of new chromophore (by appearance of new peak or merging of two peaks to generate a common peak). The TLC study showed two different spots of drug and ascorbic acid at these concentrations, confirming that no permanent interaction takes place and this aggregate formation could be only due to self-association. Moreover, unchanged IR spectra ( fig. 4 ) of solubilized product of SQ and ascorbic acid to physical mixture (1:1, SQ and ascorbic acid) confirmed that no permanent chemical interaction takes place and value of each. IR studies confirmed that complex formation had occurred. The changes in IR spectra of solubilized product of saquinavir and nicotinamide occurred mainly between wave numbers 3800-3600 and 1600-1400. IR spectra of solubilized product showed very few peaks of O-H stretch of saquinavir at 3836, 3787, 3745 and 3698, while equimolar physical mixture showed large number of peaks at 3867, 3856, 3851, 3845, 3835, 3824, 3799, 3742, 3737, 3714, 3673, 3651 was primary amide of both nicotinamide and saquinavir. Similar changes in number of peaks were observed for N-H stretch at 3300-3100; and C=C, C=N stretch at 1600 1400. The comparison with the IR of physical mixture confirmed that these differences were only due to complex formation and not because of simple overlapping in solubilized product ( fig. 4) .
Thus, complexation played a critical role in solubility enhancement of SQ by nicotinamide, which is consistent with the findings of many investigators [25] [26] [27] [28] . But the type of complex formed, whether 1:1, 1:2 or higher, was not clear. To understand the aggregation phenomenon in nicotinamide, some specific studies like UV, TLC and IR study were carried out. In UV study of these solutions at different concentrations, a shift in λ max from 262 (0.1 M) to 289 (0.8 M and higher) was observed, suggesting that complexation might have occurred. IR and TLC studies confirmed that complexation had occurred. The result of TLC study revealed single spot of solubilized product at higher concentration, which confirmed that complex formation had occurred. If this were not the case, we would have got two separate spots corresponding to R f www.ijpsonline.com
Four formulations were developed using ascorbic acid, nicotinamide, DMA ethanol and PEG200. Additives were added as per requirement of the formulation. Methyl paraben and propyl paraben (0.018% w/v and 0.02% w/ v), generally accepted preservatives for injection formulation in their standard concentration 29 , were added. Sodium bisulphate (0.1% w/v) is generally recommended for intermediate pH ranges and was therefore used in the present formulations. Formulation containing ascorbic acid as hydrotrope (SQAA) did not contain any antioxidant since ascorbic acid (solubilizing agent) also stress conditions to study the effect of light, freezing temperature, freeze thaw cycling on the formulated injection was performed. The observations were made in respect of change in colour and occurrence of precipitate. It was observed that all formulations were stable to colour change.
Formulation SQDMA showed maximum precipitate formation. The earliest precipitate appeared in freeze thaw cycling with shaking after 7 d in SQDMA, while the same formulation showed considerable stability at room functions as antioxidant.
temperature and precipitate formation occurred after 19 d. Similarly, at low temperature (4°), first precipitate in the Tonicity adjustments were made in order to produce formulation was observed after 13 d. The possible reason isotonic solution using molecular weight method 30 . Sodium for precipitate formation is the presence of nuclei in any chloride was used for tonicity adjustment. Formulations I solution, and these nuclei are expected to give rise to and II did not contain any tonicity adjuster since they crystal growth. Simultaneously, these formulations were were hypertonic; thus they could be used without any subjected to accelerated stability studies at temperatures problem. No buffering agents were used since drug 45°, 55° and 65°. The stability study testing was based on showed good stability at all pH; moreover, it might affect simplified technique of testing for liquid formulation at the solubility of formulations. Solubility studies of SQ higher temperature for longer period 37 showed higher solubility in ascorbic acid and significant change in potency of all four formulations nicotinamide; therefore, these were selected for SQNIC, SQPEGET, SQDMA, and SQAA after 145, 120, formulation development. Nicotinamide is a nontoxic 105 and 104 d respectively. vitamin (vitamin B 5 ) that has been shown to enhance solubilities of many drugs 25, 31, 32 and hence was used for All formulations were subjected to in vitro haemolytic solubilization of SQ. study using rabbit blood. The degree of haemolysis was estimated by colorimetric method. The drug and additives Similarly, ascorbic acid (vitamin C) was used in injection required to design a dosage form may have haemolytic formulation for solubility enhancement. Again this is a effect 34, 35, 38 . Hence haemolytic studies were carried out vitamin that may be beneficial as a vitamin supplement.
on the additives that were used for solubilization 16 Antioxidant nature could impart considerable stability to Haemolytic behaviour of whole formulations was studied the formulation. and reported (Table 3) . Haemolytic effects of all four formulations were found to be in the order In case of cosolvent solubilization, SQ was found to have SQAA<SQNIC<SQPEGET<SQDMA. The effects good solubility in DMF, DMA, PEG200 and ethanol.
observed were insignificant because during administration DMA, PEG200 and ethanol were used for formulation injection is diluted to nearly 25 times.
. There is no . development. Although drug showed the highest solubility enhancement in DMF, yet the use of this cosolvent has not been justified in parenteral formulation. The vehicle should contain a minimum amount of these agents to reduce toxicity and difficulties with respect to blood compatibility and injection. The safe concentrations of ethanol, propylene glycol and PEG200 are 5-50, 32 and 50% respectively in isotonic saline solutions [33] [34] [35] . Therefore ternary blend of cosolvents 36 for optimizing these factors was used in injection formulation containing PEG200 and ethanol as cosolvents (SQPEGET).
All four formulations were subjected to physical and chemical testing. Physical stability testing under different For a drug to be therapeutically active, the concentration at the site of administration should exceed its aqueous solubility. Precipitation of drug upon injecting a solubilized formulation into body fluids often occurs [39] [40] [41] . This ultimately results in poor patient compliance. The amount of precipitation can be correlated with the rate at which the drug is injected. Any remedy which reduces or eliminates precipitation ensures more efficacious formulation. Method for determination of such effect is dilution 16 . Formulation containing cosolvent showed more precipitation in comparison to hydrotrope containing formulation on dilution (Table 4) www.ijpsonline.com moreover, for higher dilution absence of precipitation is redissolution of these precipitates. Formulation SQDMA showed marked turbidity that did not disappear even at higher dilution, while formulation SQPEGET showed lesser degree of precipitate formation than formulation SQDMA. The decreasing order of precipitate formation was found as SQDMA>SQPEGET>SQAA>SQNIC.
